Protein kinase inhibitors for treatment of neurological disorders
摘要
The invention features novel derivatives of K-252a e.g. (II-4) as well as novel bis-N-substituted derivatives of staurosporine of Formula (I). The invention also features a method for treating diseased neuronal cells involving the administration of either the novel staurosporine derivatives or specified functional derivatives of K-252a. In the formula (I): ÄStauÜ - N(CH3)-W-N(CH3)-ÄStauÜ, ÄStauÜ represents a residue of formula (a) and W represents a radical of the formula: -C(=Y)-NH-W'-NH-C(=Y)- where W' is a hydrocarbylene radical of 2-20 carbon atoms and Y is O or S. In formula (II-4) R<1>, R<2>, Z<1> and Z<2> are each H; X is CH2OH; and R is OCH3.
申请公布号
EP1125938(A1)
申请公布日期
2001.08.22
申请号
EP20010110483
申请日期
1995.10.04
申请人
CEPHALON, INC.;KYOWA HAKKO KOGYO CO., LTD.
发明人
LEWIS, MICHAEL E.;KAUER, JAMES C;NEFF, NICOLA;ROBERTS-LEWIS, JILL;GLICKSMAN, MARCIE;MURAKATA, CHIKARA;SAITO, HIROMITSU;MATSUDA, YUZURU;KANAI, FUMIHIKO;KANEKO, MASAMI